Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Role of Genistein and Its Derivatives in Ovarian Cancer: New Perspectives for Molecular Mechanisms and Clinical Applications Publisher Pubmed



Chaichian S1 ; Nikfar B2 ; Bidgoli SA2, 3 ; Moazzami B2
Authors

Source: Current Medicinal Chemistry Published:2025


Abstract

Genistein (GEN) is a member of the polyphenol family, known chiefly for its effects on metabolic diseases and gynecological disorders. GEN has anti-cancer properties by inhibiting tumor proliferation, tumor metastasis, invasion, migration, and inducing apoptosis. Ovarian cancer (OC) is ranked 7th among the most common gynecological cancers. Despite its low incidence compared to other cancers, it is the first cause of death among gynecologic malignancies. Surgery and chemotherapy are the main options for treating this fatal cancer. Therefore, further investigations into GEN may aid in the discovery of novel therapeutics for preventing and/or treating OC. In this review, we aim to investigate the role of GEN in ovarian cancer. We investigate the anti-tumor effects of GEN on OC cell lines, including inducing apoptosis, suppressing tumor growth, and inhibiting metastasis. Also, we review the studies investigating GEN's roles as an adjuvant in therapeutic regimens with other chemotherapeutic agents (e.g., cisplatin, quercetin, and gemcitabine). © 2025 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Beta-Glucans Is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects, Current Pharmaceutical Biotechnology (2022)
2. Preclinical Gene Therapy in Glioblastoma Multiforme: Using Olfactory Ensheathing Cells Containing a Suicide Gene, Life Sciences (2022)
3. A Potential Role for Oridonin in Cancer Control: Mechanisms of Autophagy and Apoptosis, Current Cancer Drug Targets (2025)
Experts (# of related papers)
View all Related Experts
Zahra Azizi Varzaneh (1)
Saereh Hosseindoost (1)
Other Related Docs
4. Ovarian Cancer, Neutrophil Hitchhiking, and Nets: Unraveling Their Role in Pathogenesis and Management, Medical Oncology (2025)
5. Inhibition of C-Myc Using 10058-F4 Induces Anti-Tumor Effects in Ovarian Cancer Cells Via Regulation of Foxo Target Genes, European Journal of Pharmacology (2021)
6. Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers, International Journal of Cancer Management (2016)
7. The Obeticholic Acid Can Positively Regulate the Cancerous Behavior of Mcf7 Breast Cancer Cell Line, Molecular Biology Reports (2024)
8. Sirna and Epigenetic Aberrations in Ovarian Cancer, Journal of Cancer Research and Therapeutics (2016)
9. Ovarian Cancer in the World: Epidemiology and Risk Factors, International Journal of Women's Health (2019)
10. Mirnas: Emerging Agents for Therapeutic Effects of Polyphenols on Ovarian Cancer, Mini-Reviews in Medicinal Chemistry (2024)
11. The Role of Natural Products As Inhibitors of Jak/Stat Signaling Pathways in Glioblastoma Treatment, Oxidative Medicine and Cellular Longevity (2022)
12. Nanoparticle-Sirna: A Potential Strategy for Ovarian Cancer Therapy?, Nanomedicine (2019)
13. Gene Therapy: A Promising Approach for Breast Cancer Treatment, Cell Biochemistry and Function (2022)
14. Lncrnas and Mirnas: New Targets for Resveratrol in Ovarian Cancer Research, Current Medicinal Chemistry (2023)
15. Apigenin in Cancer Therapy: Prevention of Genomic Instability and Anticancer Mechanisms, Clinical and Experimental Pharmacology and Physiology (2023)